栄研化学(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4549/E00961 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/05/02 | 日証協 | 57,810株 | +45.47% | 100,862株 | -10.24% | 111,460株 | +45.83% | 65,300株 | +196.95% |
| 2013/04/26 | 日証協 | 39,740株 | +64.71% | 112,374株 | +175.21% | 76,432株 | +4.6% | 21,990株 | +67.24% |
| 2013/04/19 | 日証協 | 24,127株 | -1.12% | 40,832株 | +90.8% | 73,071株 | -4.45% | 13,149株 | -54.04% |
| 2013/04/12 | 日証協 | 24,400株 | +41.62% | 21,400株 | -9.62% | 76,471株 | +45.74% | 28,610株 | +95.82% |
| 2013/04/05 | 日証協 | 17,229株 | -3.69% | 23,678株 | +91.45% | 52,471株 | +3.38% | 14,610株 | -25.45% |
| 2013/03/29 | 日証協 | 17,890株 | -43.62% | 12,368株 | -5.59% | 50,757株 | -27.99% | 19,597株 | -20.37% |
| 2013/03/22 | 日証協 | 31,729株 | +61.06% | 13,100株 | -62.99% | 70,483株 | -6.82% | 24,610株 | -56.19% |
| 2013/03/15 | 日証協 | 19,700株 | -54.4% | 35,400株 | -41.68% | 75,644株 | +21.12% | 56,180株 | +791.75% |
| 2013/03/08 | 日証協 | 43,200株 | +25.58% | 60,700株 | +117.56% | 62,454株 | +5.76% | 6,300株 | +3050% |
| 2013/03/01 | 日証協 | 34,400株 | +7.17% | 27,900株 | -55.29% | 59,054株 | -1.17% | 200株 | -99.01% |
| 2013/02/22 | 日証協 | 32,100株 | -24.11% | 62,400株 | +47.87% | 59,754株 | -10.75% | 20,101株 | +1575.08% |
| 2013/02/15 | 日証協 | 42,300株 | +25.52% | 42,200株 | +89.15% | 66,953株 | -22.56% | 1,200株 | -47.85% |
| 2013/02/08 | 日証協 | 33,700株 | -16.58% | 22,310株 | -57.91% | 86,453株 | -10.64% | 2,301株 | -88.77% |
| 2013/02/01 | 日証協 | 40,400株 | -24.34% | 53,000株 | +8.38% | 96,743株 | -0.01% | 20,490株 | +173.2% |
| 2013/01/25 | 日証協 | 53,400株 | +20.27% | 48,900株 | +190.22% | 96,753株 | -1.92% | 7,500株 | +519.83% |
| 2013/01/18 | 日証協 | 44,400株 | -0.22% | 16,849株 | +240.32% | 98,643株 | -2.45% | 1,210株 | -79.17% |
| 2013/01/11 | 日証協 | 44,500株 | -0.89% | 4,951株 | +312.58% | 101,125株 | +3.69% | 5,808株 | +2804% |
| 2013/01/04 | 日証協 | 44,900株 | -2.81% | 1,200株 | -94.91% | 97,525株 | +0.1% | 200株 | -90.48% |
| 2012/12/28 | 日証協 | 46,200株 | -1.72% | 23,559株 | +3.46% | 97,425株 | +0.62% | 2,100株 | +75% |
※株式分割は考慮していませんのでご注意ください。
Page Top